Alireza Esteghamati, Mojtaba Malek, Farhad Hosseinpanah Ghasabeh, Farzad Hadaegh, Mohammad Afkhami-Ardekani, Hamid Reza Aghai Meybodi, Mohammad Hossein Dabbaghmanesh, Fatemeh Ghaemi, Seyed Adel Jahed, Saeed Kalbasi, Mojtaba Mehrdad, Zohreh Mousavi, Mitra Niafar, Hassan Rezvanian, Mojgan Sanjari, Amir Ziaee, Mohammad E Khamseh
{"title":"A Consensus Report on Management of Type 2 Diabetes Mellitus in Iran.","authors":"Alireza Esteghamati, Mojtaba Malek, Farhad Hosseinpanah Ghasabeh, Farzad Hadaegh, Mohammad Afkhami-Ardekani, Hamid Reza Aghai Meybodi, Mohammad Hossein Dabbaghmanesh, Fatemeh Ghaemi, Seyed Adel Jahed, Saeed Kalbasi, Mojtaba Mehrdad, Zohreh Mousavi, Mitra Niafar, Hassan Rezvanian, Mojgan Sanjari, Amir Ziaee, Mohammad E Khamseh","doi":"10.47176/mjiri.39.13","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Type 2 diabetes mellitus (T2DM) is one of the most serious public health problems all over the world. Development of local consensus on management of T2DM, providing clinicians, researchers, and policymakers with updated and valid evidence in consideration of practical issues, is crucial. Therefore, we aimed to develop a consensus report on management of T2DM in Iran.</p><p><strong>Methods: </strong>A task force group comprised of experts in diabetes management reviewed published literature. The task force members reached the majority agreement on all recommendations after participating in several group meeting discussions.</p><p><strong>Results: </strong>The consensus provided recommendations on diverse aspects on management of people with T2DM in Iran. The recommendations covered the following topics: first-line treatment, diabetes management in people with obesity, combination therapy in people with T2DM, injectable therapy, and non-alcoholic fatty liver in people with T2DM.</p><p><strong>Conclusion: </strong>Considering evidence-based guidelines, the task force group developed a consensus to address important clinical issues in the management of people with T2DM in Iran.</p>","PeriodicalId":18361,"journal":{"name":"Medical Journal of the Islamic Republic of Iran","volume":"39 ","pages":"13"},"PeriodicalIF":0.0000,"publicationDate":"2025-01-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12138759/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medical Journal of the Islamic Republic of Iran","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.47176/mjiri.39.13","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Type 2 diabetes mellitus (T2DM) is one of the most serious public health problems all over the world. Development of local consensus on management of T2DM, providing clinicians, researchers, and policymakers with updated and valid evidence in consideration of practical issues, is crucial. Therefore, we aimed to develop a consensus report on management of T2DM in Iran.
Methods: A task force group comprised of experts in diabetes management reviewed published literature. The task force members reached the majority agreement on all recommendations after participating in several group meeting discussions.
Results: The consensus provided recommendations on diverse aspects on management of people with T2DM in Iran. The recommendations covered the following topics: first-line treatment, diabetes management in people with obesity, combination therapy in people with T2DM, injectable therapy, and non-alcoholic fatty liver in people with T2DM.
Conclusion: Considering evidence-based guidelines, the task force group developed a consensus to address important clinical issues in the management of people with T2DM in Iran.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
